Cutler Group’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Cutler Group’s Portfolio CTIC Stock Details CTIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Hold	0	–	–	–	5468
2022 Q4	–	Sell	-540	Closed	-$2.95K	–	5986
2022 Q3	$3K	Sell	540 -14,065	-96%	-$87.7K	﹤0.01%	4114
2022 Q2	$87K	Sell	14,605 -12,414	-46%	-$63.6K	0.01%	1531
2022 Q1	$126K	Buy	+27,019	New	+$80.6K	0.01%	1535
2017 Q2	–	Sell	-784	Closed	-$3K	–	8064
2017 Q1	$3K	Hold	784	–	–	﹤0.01%	5326
2016 Q4	$3K	Hold	784	–	–	﹤0.01%	5503
2016 Q3	$2K	Hold	784	–	–	﹤0.01%	5960
2016 Q2	$2K	Hold	784	–	–	﹤0.01%	5920
2016 Q1	$4K	Sell	784 -210	-21%	-$1.68K	﹤0.01%	5182
2015 Q4	$12K	Buy	+994	New	+$13.3K	﹤0.01%	4005

Other funds holding CTIC

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Stonepine Capital Management Bend, Oregon $114M AUM 77.6% 1-Year Est. Return

Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return